The Novo Nordisk A/S (NVO) ROIC is 42.9%, compared to the industry median of ((125.1%)) and the 5-year historical average of 36.7%.
The Novo Nordisk A/S (NVO) ROIC minus WACC is 35.9%, compared to the industry median of ((131.8%)) and the 5-year historical average of 30.9%.
The Novo Nordisk A/S (NVO) ROE is 81.3%, compared to the industry median of ((52.2%)) and the 5-year historical average of 74.5%.
The Novo Nordisk A/S (NVO) ROCE is 50.8%, compared to the industry median of ((51.2%)) and the 5-year historical average of 55.2%.